CAB-LA is a Highly Effective HIV Prevention Option; Now what?

Dec 17, 2020, 01:47 AM
Early results from trials testing cabotegravir as a long-acting injectable PrEP show it was safe and highly effective against HIV. Listen to learn what must come next for CAB-LA to advance HIV prevention alongside oral PrEP and the Dapivirine Vaginal Ring?